1. Home
  2. UNTY vs EDIT Comparison

UNTY vs EDIT Comparison

Compare UNTY & EDIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unity Bancorp Inc.

UNTY

Unity Bancorp Inc.

HOLD

Current Price

$59.11

Market Cap

539.4M

Sector

Finance

ML Signal

HOLD

Logo Editas Medicine Inc.

EDIT

Editas Medicine Inc.

HOLD

Current Price

$3.25

Market Cap

432.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UNTY
EDIT
Founded
1991
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
539.4M
432.8M
IPO Year
2014
2016

Fundamental Metrics

Financial Performance
Metric
UNTY
EDIT
Price
$59.11
$3.25
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
$65.00
$5.30
AVG Volume (30 Days)
50.5K
1.5M
Earning Date
04-14-2026
05-11-2026
Dividend Yield
1.23%
N/A
EPS Growth
39.66
37.50
EPS
2.82
N/A
Revenue
N/A
$31,937,000.00
Revenue This Year
$12.14
N/A
Revenue Next Year
$9.56
N/A
P/E Ratio
$21.34
N/A
Revenue Growth
N/A
132.64
52 Week Low
$44.34
$1.66
52 Week High
$62.50
$4.54

Technical Indicators

Market Signals
Indicator
UNTY
EDIT
Relative Strength Index (RSI) 51.26 60.95
Support Level $51.27 $2.40
Resistance Level $60.49 $3.21
Average True Range (ATR) 1.09 0.17
MACD -0.08 0.03
Stochastic Oscillator 27.76 75.97

Price Performance

Historical Comparison
UNTY
EDIT

About UNTY Unity Bancorp Inc.

Unity Bancorp Inc is a bank holding company that serves as a holding company for Unity Bank. The Company has elected to become a financial holding company pursuant to regulations of the Board of Governors of the Federal Reserve System (the FRB). The Company's primary business is ownership and supervision of the Bank. The Company and the Bank derive a majority of their revenue from net interest income (i.e., the difference between the interest received on loans and securities and the interest paid on deposits and borrowings). The Company, through the Bank, conducts a traditional and community-oriented commercial banking business and services, personal and business checking accounts, time deposits, money market accounts, savings accounts, credit cards, automated teller service, and others.

About EDIT Editas Medicine Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.

Share on Social Networks: